Within the Dental Tissue Ablation Laser market, segmentation by type distinguishes the distinct laser architectures that drive adoption. Erbium:YAG lasers, operating at 2,940 nm, exhibit high water absorption, enabling precise hard‑tissue removal with minimal thermal damage; they command the largest share, roughly 38 % of total revenue, due to broad acceptance in cavity preparation. Erbium:Cr:YSGG lasers (2,780 nm) provide comparable ablation efficiency while offering enhanced soft‑tissue versatility, contributing an estimated 22 % of market size. CO₂ lasers (10,600 nm) excel in soft‑tissue coagulation but are limited in hard‑tissue efficacy, accounting for about 15 % of sales. Diode lasers (810–980 nm) are primarily used for soft‑tissue procedures and periodontal therapy, representing 13 % of the market. Nd:YAG lasers (1,064 nm) deliver deeper penetration for hemostasis and bacterial reduction, supporting a niche 12 % share. This type‑based taxonomy clarifies how wavelength‑dependent performance characteristics allocate revenue across the Dental Tissue Ablation Laser segmentation.